prednimustine
|
|
prednimustine Eigenschaften
- Schmelzpunkt:
- 163-164°
- alpha
- D24 +92.9° (c = 1.06 in chloroform)
- Siedepunkt:
- 791.5±60.0 °C(Predicted)
- Dichte
- 1.30±0.1 g/cm3(Predicted)
- pka
- 12.32±0.70(Predicted)
- IARC
- 3 (Vol. 50) 1990
Sicherheit
Giftige Stoffe Daten | 29069-24-7(Hazardous Substances Data) |
---|
prednimustine Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Antineoplastic.prednimustine Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
prednimustine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 8)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Dideu Industries Group Limited | +86-29-89586680 +86-15129568250 |
1026@dideu.com | China | 22787 | 58 |
LGM Pharma | 1-(800)-881-8210 |
inquiries@lgmpharma.com | United States | 2123 | 70 |
Shaanxi Dideu Newmaterial Co., Ltd. | 029-87576359 15353716720 |
1039@dideu.com | China | 10009 | 58 |
29069-24-7()Verwandte Suche:
- prednimustine
- Prednimustin
- 21-[4-[p-[Bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy]-11β,17-dihydroxypregna-1,4-diene-3,20-dione
- Chlorambucil prednisolone ester
- LEO-1031
- NSC-134087
- Stereocyt
- NSC 171345
- Prednisolone chloraMbucil ester
- Sterecyt
- HFVNWDWLWUCIHC-GUPDPFMOSA-N
- Pregna-1,4-diene-3,20-dione, 21-[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy]-11,17-dihydroxy-, (11β)-
- prednimustine USP/EP/BP
- 29069-24-7
- C35H45Cl2NO6